Page last updated: 2024-11-04

sulfathiazole and Endocarditis

sulfathiazole has been researched along with Endocarditis in 1 studies

Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.

Endocarditis: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BAUER, J1
ARNDAL, O1

Other Studies

1 other study available for sulfathiazole and Endocarditis

ArticleYear
Arthritic syndromes; Reiter's disease followed by endocarditis and lupus erythematosus disseminatus after sulfathiazole treatment.
    The Medical world, 1946, Volume: 159

    Topics: Arthritis; Arthritis, Reactive; Endocarditis; Humans; Lupus Erythematosus, Systemic; Sulfathiazole;

1946